0001441844-11-000013.txt : 20110405
0001441844-11-000013.hdr.sgml : 20110405
20110405094812
ACCESSION NUMBER: 0001441844-11-000013
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110401
FILED AS OF DATE: 20110405
DATE AS OF CHANGE: 20110405
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ISRAEL ROBERT J
CENTRAL INDEX KEY: 0001250274
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23143
FILM NUMBER: 11738334
MAIL ADDRESS:
STREET 1: 50 OXFORD DR
CITY: MONTEBELLE
STATE: NY
ZIP: 10901
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PROGENICS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000835887
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133379479
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9147892800
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0303
4
2011-04-01
0
0000835887
PROGENICS PHARMACEUTICALS INC
PGNX
0001250274
ISRAEL ROBERT J
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
0
1
0
0
Sr. VP, Medical Affairs
Common Stock
2011-04-01
4
M
0
1000
5.33
A
44377
D
Common Stock
2011-04-01
4
S
0
1000
6.33
D
43377
D
Common Stock
2011-04-01
4
M
0
3332
5.05
A
46953
D
Common Stock
2011-04-01
4
F
0
2913
6.29
D
44040
D
ESPP (right to buy)
5.05
2011-04-01
4
M
0
3332
0
D
2011-04-01
2011-04-01
Common Stock
3332
0
D
ESPP (right to buy)
6.18
2011-04-01
4
A
0
2872
0
A
2011-10-01
2011-10-01
Common Stock
2872
2872
D
Non-Qualified Stock Option (right to buy)
5.33
2011-04-01
4
M
0
1000
0
D
2011-04-01
2019-07-01
Common Stock
1000
40000
D
The Reporting Person is exercising options under this grant in pre-established increments under and in accordance with provisions of a previously established Plan of Sale under Rule 10b5-1, which was established in accordance with the policies and procedures of the Issuer.
Acquired upon the complete exercise of a grant under the Non-Qualified Employee Stock Purchase Plan, which grant was previously reported at the start of a six month option term, to acquire common stock up to an option amount which is 25% of the optionee's quarterly salary less $6,250, at a purchase price equal to the lower of 100% of the market value on the date of grant or 85% of the market value on the date of exercise.
Includes shares of common stock acquired from the non-reportable exercise of a Grant under the Qualified Employee Stock Purchase Plan.
Granted under the Company's Non-Qualified Employeee Stock Purchase Plan.
The option was granted on the first day of the option term and previously reported as a right to purchase shares of the Company's common stock at an exercise price equal to the market value on the date of grant. In accordance with the Non-Qualified Employee Stock Purchase Plan, the option is ultimately exercisable for an exercise price which is the lower of 100% of the market value on the grant date or 85% of the market value on the exercise date. The number of shares acquired upon exercise is based on the option amount divided by the lower of 100% of the market value on the grant date or 85% of the market value on the exercise date.
The option will be exercisable for that number of shares equal to the option amount (25% of the optionee's quarterly salary less $6,250) divided by the lesser of the market value of the common stock on the grant date or 85% of the market value on the exercise date.
By: Robert A. McKinney For: Robert J. Israel
2011-04-05